Adjuvant high‐dose intravenous gammaglobulin in the treatment of pemphigus and bullous pemphigoid: experience in six patients

At present, initial high‐dose prednisone is the treatment of choice for patients with pemphigus and bullous pemphigoid. To reduce the risks associated with long‐term corticosteroid treatment, other immunosuppressants are often given as steroid‐sparing agents. Occasionally, the dose of steroids cannot be reduced. In this study, we report six patients with pemphigus vulgaris, pemphigus foliaceus and bullous pemphigoid, in whom the daily corticosteroid dose could only be tapered to acceptable, effective, maintenance levels following treatment with high‐dose intravenous gammaglobulin.

[1]  W. Westerhof,et al.  Treatment of generalized bullous pemphigoid with oral tetracycline. , 1994, Journal of the American Academy of Dermatology.

[2]  J. Dwyer.  Manipulating the immune system with immune globulin. , 1992, The New England journal of medicine.

[3]  P. Agache,et al.  Effects of intravenous γ-globulin in pemphigus , 1990 .

[4]  A. Steiner,et al.  High-dosage intravenous gamma globulin: therapeutic failure in pemphigus and pemphigoid. , 1989, Journal of the American Academy of Dermatology.

[5]  P. Millard,et al.  Dapsone as first line therapy for bullous pemphigoid , 1989, The British journal of dermatology.

[6]  Jean Kanitakis,et al.  Treatment of nine cases of pemphigus vulgaris with cyclosporine. , 1988, Journal of the American Academy of Dermatology.

[7]  J. Roujeau,et al.  Bullous pemphigoid and intravenous gammaglobulin. , 1985, Annals of internal medicine.

[8]  Y. Poulin,et al.  Pemphigus vulgaris: results of treatment with gold as a steroid-sparing agent in a series of thirteen patients. , 1984, Journal of the American Academy of Dermatology.

[9]  M. Kazatchkine,et al.  ANTI-IDIOTYPIC SUPPRESSION OF AUTOANTIBODIES TO FACTOR VIII (ANTIHAEMOPHILIC FACTOR) BY HIGH-DOSE INTRAVENOUS GAMMAGLOBULIN , 1984, The Lancet.

[10]  D. Baruah.  Bilateral spontaneous rupture of the Achilles tendons in a patient on long-term systemic steroid therapy. , 1984, British journal of sports medicine.

[11]  J. Roujeau,et al.  Plasma exchange in pemphigus. Uncontrolled study of ten patients. , 1983, Archives of dermatology.

[12]  B. Dupont,et al.  Identification by HLA typing of intrauterine-derived maternal T cells in four patients with severe combined immunodeficiency. , 1982, The New England journal of medicine.

[13]  C. Cunningham-Rundles,et al.  Antinuclear antibody staining only centrioles in a patient with scleroderma. , 1982 .

[14]  C. Cunningham-Rundles,et al.  High-dose intravenous gamma globulin for autoimmune neutropenia. , 1982, The New England journal of medicine.

[15]  A. Hirt,et al.  HIGH-DOSE INTRAVENOUS GAMMAGLOBULIN FOR IDIOPATHIC THROMBOCYTOPENIC PURPURA IN CHILDHOOD , 1981, The Lancet.

[16]  W. Eaglstein,et al.  Management of pemphigus with gold compounds: a long-term follow-up report. , 1976, Archives of dermatology.